{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T15:34:17Z","timestamp":1792251257395,"version":"4.4.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1007\/s12185-024-03731-1","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T06:39:41Z","timestamp":1711521581000},"page":"532-540","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hereditary TTP\/Upshaw\u2013Schulman syndrome: the ductus arteriosus controls newborn survival"],"prefix":"10.1007","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4887-5741","authenticated-orcid":false,"given":"Yoshihiro","family":"Fujimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,27]]},"reference":[{"key":"3731_CR1","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/B978-1-4160-4224-2.50029-6","volume-title":"Creasy & Resnik\u2019s maternal-fetal medicine; principles and practice","author":"KJ Moises","year":"2009","unstructured":"Moises KJ. Hemolytic disease of the fetus and newborn. In: Creasy RK, Iams JD, Lockwood CJ, Moore TR, editors. Creasy & Resnik\u2019s maternal-fetal medicine; principles and practice. 6th ed. Philadephia, PA: Elsevier; 2009. p. 477\u2013503.","edition":"6"},{"issue":"1","key":"3731_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/tme.12099","volume":"24","author":"M De Haas","year":"2014","unstructured":"De Haas M, Finning K, Massey E, Roberts DJ. Anti-D prophylaxis: past, present and future. Transfus Med. 2014;24(1):1\u20137.","journal-title":"Transfus Med"},{"issue":"5","key":"3731_CR3","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1046\/j.1537-2995.1980.20581034512.x","volume":"20","author":"FJ Grundbacher","year":"1980","unstructured":"Grundbacher FJ. The etiology of ABO hemolytic disease of the newborn. Transfusion. 1980;20(5):563\u20138.","journal-title":"Transfusion"},{"issue":"3","key":"3731_CR4","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1111\/j.1423-0410.2011.01539.x","volume":"102","author":"MEA Rath","year":"2012","unstructured":"Rath MEA, Smits-Wintjnes VEHJ, Oepkes D, van Zwet EW, van Kamp IL, Brand A, et al. Thrombocytopenia at birth in neonates with red cell alloimmune haemolytic disease. Vox Sang. 2012;102(3):228\u201333.","journal-title":"Vox Sang"},{"key":"3731_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-023-03657-0","author":"M Matsumoto","year":"2023","unstructured":"Matsumoto M, Miyakawa Y, Kokame K, Ueda Y, Wada H, Higasa S, et al. Diagnostic and treatment guidelines for thrombotic thrombocytopenic purpura (TTP) in Japan. Int J Hematol. 2023. https:\/\/doi.org\/10.1007\/s12185-023-03657-0.","journal-title":"Int J Hematol"},{"issue":"8","key":"3731_CR6","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1111\/j.1538-7836.2011.04399.x","volume":"9","author":"K Kokame","year":"2011","unstructured":"Kokame K, Kokubo Y, Miyata T. Polymorphisms and mutations of ADAMTS13 in the Japanese population and estimation of the number of patients with Upshaw-Schulman syndrome. J Thromb Haemost. 2011;9(8):1654\u20136.","journal-title":"J Thromb Haemost"},{"key":"3731_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12863-021-01010-0","volume":"22","author":"T Zhao","year":"2021","unstructured":"Zhao T, Fan S, Sun L. The global carrier frequency and genetic prevalence of Upshaw-Schulman syndrome. BMC Genomic Data. 2021;22:22\u201350.","journal-title":"BMC Genomic Data"},{"issue":"17","key":"3731_CR8","doi-asserted-by":"publisher","first-page":"1653","DOI":"10.1056\/NEJMra1813013","volume":"381","author":"JA Kremer-Hovinga","year":"2019","unstructured":"Kremer-Hovinga JA, George JN. Hereditary thrombotic thrombocytopenic purpura. New Eng J Med. 2019;381(17):1653\u201362.","journal-title":"New Eng J Med"},{"issue":"25","key":"3731_CR9","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1056\/NEJMc2210781","volume":"387","author":"MJ Stubbs","year":"2022","unstructured":"Stubbs MJ, Kendall G, Scully M. Recombinant ADAMTS13 in severe neonatal thrombotic thrombocytopenic purpura. New Engl J Med. 2022;387(25):2391\u20132.","journal-title":"New Engl J Med"},{"issue":"1","key":"3731_CR10","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S0022-3476(67)80241-5","volume":"71","author":"LA Monnens","year":"1967","unstructured":"Monnens LA, Retera RJ. Thrombotic thrombocytopenic purpura in a neonatal infant. J Pediatrics. 1967;71(1):118\u201323.","journal-title":"J Pediatrics"},{"key":"3731_CR11","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF02982558","volume":"74","author":"S Kinoshita","year":"2001","unstructured":"Kinoshita S, Yoshioka A, Park Y-D, Ishizashi H, Konno M, Funato M, et al. Upshaw-Schulman syndrome revisited: a concept of congenital thrombotic thrombocytopenic purpura. Int J Hematol. 2001;74:101\u20138.","journal-title":"Int J Hematol"},{"issue":"6855","key":"3731_CR12","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1038\/35097008","volume":"413","author":"GG Levy","year":"2001","unstructured":"Levy GG, Nichols WC, Lian EC, Foroud F, McClintick JN, McGee BM, et al. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura. Nature. 2001;413(6855):488\u201394.","journal-title":"Nature"},{"issue":"Suppl 1","key":"3731_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1111\/j.1538-7836.2011.04341.x","volume":"9","author":"Y Fujimura","year":"2011","unstructured":"Fujimura Y, Matsumoto M, Isonishi A, Yagi H, Kokame K, Soejima K, et al. Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan. J Thromb Haemost. 2011;9(Suppl 1):283\u2013301.","journal-title":"J Thromb Haemost"},{"key":"3731_CR14","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/978-3-319-08717-7_5","volume-title":"ADAMTS13 biology and disease","author":"Y Fujimura","year":"2015","unstructured":"Fujimura Y, Kokame K, Yagi H, Isonishi A, Matsumtoto M, Miyata T. Hereditary deficiency of ADAMTS13 activity: Upshaw-Schulman syndrome. In: Rodgers GM, editor. ADAMTS13 biology and disease. Cham: Springer; 2015. p. 73\u201390."},{"issue":"21","key":"3731_CR15","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1182\/bloodadvances.2019000601","volume":"3","author":"Y Fujimura","year":"2019","unstructured":"Fujimura Y, L\u00e4mmle B, Tanabe S, Sakai K, Kimura T, Kokame K, et al. Patent ductus arteriosus generates neonatal hemolytic jaundice with thrombocytopenia in Upshaw-Schulman syndrome. Blood Adv. 2019;3(21):3191\u20135.","journal-title":"Blood Adv"},{"key":"3731_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.21037\/aob-22-17","volume":"8","author":"K Sakai","year":"2023","unstructured":"Sakai K, Hamada E, Kokame K, Matsumoto M. Congenital thrombotic thrombocytopenic purpura: genetics and emerging therapies. Ann Blood. 2023;8:24.","journal-title":"Ann Blood"},{"key":"3731_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/jth.13186","volume":"14","author":"AS von Krogh","year":"2016","unstructured":"von Krogh AS, Quist-Paulsen P, Waage A, Langseth OO, Thorstensen K, Brudevold R, et al. High prevalence of hereditary thrombotic thrombocytopenic purpura in central Norway: from clinical observations to evidence. J Thromb Haemost. 2016;14:73\u201382.","journal-title":"J Thromb Haemost"},{"issue":"25","key":"3731_CR18","doi-asserted-by":"publisher","first-page":"3563","DOI":"10.1182\/blood.2020009801","volume":"137","author":"E Tarasco","year":"2021","unstructured":"Tarasco E, Butikofer L, Friedman KD, George JN, Hrachovinova I, Kn\u00f6bl PN, et al. Annual incidence and severity of acute episodes in hereditary thrombotic thrombocytopenic purpura. Blood. 2021;137(25):3563\u201375.","journal-title":"Blood"},{"issue":"11","key":"3731_CR19","doi-asserted-by":"publisher","first-page":"1902","DOI":"10.1055\/s-0038-1673686","volume":"118","author":"BS Joly","year":"2018","unstructured":"Joly BS, Boisseau P, Roose E, Stepanian A, Biebuyck N, Hogan J, et al. ADAMTS13 gene mutations influence ADAMTS13 conformation and disease age-onset in the French cohort of Upshaw-Schulman syndrome. Thromb Haemost. 2018;118(11):1902\u201317.","journal-title":"Thromb Haemost"},{"issue":"15","key":"3731_CR20","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1182\/blood-2018-11-884700","volume":"133","author":"F Alwan","year":"2019","unstructured":"Alwan F, Vendramin C, Liesner R, Clark A, Lester W, Dutt T, et al. Characterization and treatment of congenital thrombotic thrombocytopenic purpura. Blood. 2019;133(15):1644\u201351.","journal-title":"Blood"},{"issue":"7","key":"3731_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12820.eCollection","volume":"6","author":"J Liu","year":"2022","unstructured":"Liu J, Zhang Y, Li Z, Zhang L, Jian S, Wang C, et al. Early indicators of neonatal onset of hereditary thrombotic thrombocytopenic purpura. Res Pract Thromb Haemost. 2022;6(7): e12820. https:\/\/doi.org\/10.1002\/rth2.12820.eCollection.","journal-title":"Res Pract Thromb Haemost"},{"issue":"2","key":"3731_CR22","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1053\/beha.2001.0142","volume":"14","author":"M Furlan","year":"2001","unstructured":"Furlan M, L\u00e4mmle B. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease. Best Pract Res Clin Haemat. 2001;14(2):437\u201354.","journal-title":"Best Pract Res Clin Haemat"},{"key":"3731_CR23","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.40","volume":"6","author":"JN George","year":"2022","unstructured":"George JN. Hereditary thrombotic thrombocytopenic purpura: the risk for death at birth. Res Pract Thromb Haemost. 2022;6: e12840. https:\/\/doi.org\/10.1002\/rth2.40.","journal-title":"Res Pract Thromb Haemost"},{"issue":"4","key":"3731_CR24","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1152\/physrev.00032.2009","volume":"90","author":"Y Gao","year":"2010","unstructured":"Gao Y, Usha-Raj J. Regulation of the pulmonary circulation in the fetus and newborn. Physiol Rev. 2010;90(4):1291\u2013335.","journal-title":"Physiol Rev"},{"issue":"1","key":"3731_CR25","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.jpeds.2018.04.051","volume":"200","author":"A Jain","year":"2018","unstructured":"Jain A, Mohamed A, Kavanaugh B, Shah PS, Kuipers BCW, El-Khuiffash A, et al. Cardiopulmonary adaptation during the first day of life in human neonates. J Pediat. 2018;200(1):50\u20137.","journal-title":"J Pediat"},{"key":"3731_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.590578.eCollection","volume":"8","author":"S Parkerson","year":"2021","unstructured":"Parkerson S, Philip R, Talati A, Sathanandam S. Management of patent ductus arteriosus in premature infants in 2020. Front Pediatr. 2021;8: 590578. https:\/\/doi.org\/10.3389\/fped.2020.590578.eCollection.","journal-title":"Front Pediatr"},{"issue":"17","key":"3731_CR27","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1161\/CIRCULATIONAHA.105.592063","volume":"114","author":"DJ Schneider","year":"2006","unstructured":"Schneider DJ, Moore JW. Patent ductus arteriosus. Circulation. 2006;114(17):1873\u201382.","journal-title":"Circulation"},{"issue":"7","key":"3731_CR28","doi-asserted-by":"publisher","first-page":"1861","DOI":"10.3390\/ijms19071861","volume":"19","author":"Y-C Hung","year":"2018","unstructured":"Hung Y-C, Yeh J-L, Hsu J-H. Molecular mechanisms for regulating postnatal ductus arteriosus closure. Int J Mol Sci. 2018;19(7):1861. https:\/\/doi.org\/10.3390\/ijms19071861.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3731_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nm.2060","volume":"16","author":"K Echtler","year":"2010","unstructured":"Echtler K, Stark K, Lorenz M, Kerstan S, Walch A, Jennen L, et al. Platelets contribute to postnatal occlusion of the ductus arteriosus. Nature Med. 2010;16(1):75\u201382. https:\/\/doi.org\/10.1038\/nm.2060.","journal-title":"Nature Med"},{"issue":"11","key":"3731_CR30","doi-asserted-by":"publisher","first-page":"3026","DOI":"10.1172\/JCI28639","volume":"116","author":"U Yokoyama","year":"2006","unstructured":"Yokoyama U, Minamisawa S, Quan H, Ghatak S, Akaike T, Segi-Nisbhida E, et al. Chronic activation of the prostaglandin receptor EP4 promotes hyaluronan-mediated neointimal formation in the ductus arteriosus. J Clin Invest. 2006;116(11):3026\u201334. https:\/\/doi.org\/10.1172\/JCI28639.","journal-title":"J Clin Invest"},{"issue":"23","key":"3731_CR31","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1056\/NEJM198212023072306","volume":"307","author":"JL Moake","year":"1982","unstructured":"Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, et al. Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. New Eng J Med. 1982;307(23):1432\u20135.","journal-title":"New Eng J Med"},{"key":"3731_CR32","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1056\/NEJM197712222972507","volume":"297","author":"JJ Byrnes","year":"1977","unstructured":"Byrnes JJ, Khurana M. Treatment of thrombotic thrombocytopenic purpura with plasma. New Eng J Med. 1977;297:1386\u20139.","journal-title":"New Eng J Med"},{"issue":"1","key":"3731_CR33","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1182\/blood.V16.1.943.943","volume":"16","author":"I Schulman","year":"1960","unstructured":"Schulman I, Pierce M, Lukens A, Currimbhoy Z. Studies on thrombopoiesis: I. A factor in normal plasma required for platelet production: chronic thrombocytopenia due to its deficiency. Blood. 1960;16(1):943\u201357.","journal-title":"Blood"},{"key":"3731_CR34","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1182\/blood.V53.2.333.333","volume":"53","author":"ECY Lian","year":"1979","unstructured":"Lian ECY, Harkness DR, Byrnes JJ, Wallach H, Nunez R. Presence of a platelet aggregating factor in the plasma of patients with thrombotic thrombocytopenic purpura (TTP) and its inhibition by normal plasma. Blood. 1979;53:333\u20138.","journal-title":"Blood"},{"issue":"24","key":"3731_CR35","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1056\/NEJM197806152982407","volume":"298","author":"JDJ Upshaw","year":"1978","unstructured":"Upshaw JDJ. Congenital deficiency of a factor in normal plasma that reverses microangiopathic hemolysis and thrombocytopenia. New Eng J Med. 1978;298(24):1350\u20132.","journal-title":"New Eng J Med"},{"key":"3731_CR36","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1182\/bloodadvances.2017013995","volume":"18","author":"T Kalagara","year":"2018","unstructured":"Kalagara T, Moutsis T, Yang Y, Pappelbaum KI, Farken A, Cladder-Micus L, et al. The endothelial glycocalyx anchors von Willebrand factor fibers to the vascular endothelium. Blood adv. 2018;18:2347\u201357.","journal-title":"Blood adv"},{"issue":"12","key":"3731_CR37","doi-asserted-by":"publisher","first-page":"4033","DOI":"10.1182\/blood-2002-05-1401","volume":"100","author":"J-F Dong","year":"2002","unstructured":"Dong J-F, Moake JL, Nolasco L, Bernardo A, Arceneaux W, Shrimpton CN, et al. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood. 2002;100(12):4033\u20139.","journal-title":"Blood"},{"key":"3731_CR38","doi-asserted-by":"publisher","first-page":"E304","DOI":"10.1002\/ajh.26603","volume":"97","author":"B Shao","year":"2022","unstructured":"Shao B, Nusrat S, George JN, Xia L. Aspirin prophylaxis for hereditary and acquired thrombotic thrombocytopenic purpura. Amer J Hematolo. 2022;97:E304\u20136.","journal-title":"Amer J Hematolo"},{"issue":"4","key":"3731_CR39","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1111\/j.1365-2141.1981.tb02689.x","volume":"47","author":"SS Johnson","year":"1981","unstructured":"Johnson SS, Montgomery RR, Hathaway W. Newborn factor VIII complex: elevated activities in term infants and alterations in electrophoretic mobility related to illness and activated coagulation. Brit J Haematol. 1981;47(4):597\u2013660.","journal-title":"Brit J Haematol"},{"key":"3731_CR40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1182\/blood.V70.1.165.165","volume":"70","author":"M Andrew","year":"1987","unstructured":"Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefsen DM, et al. Development of the human coagulation system in the full-term infant. Blood. 1987;70:165\u201372.","journal-title":"Blood"},{"key":"3731_CR41","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1651-2227.1995.tb13733.x","volume":"84","author":"KB Thomas","year":"1995","unstructured":"Thomas KB, Sutor AH, Altinkaya N, Grohmann A, Zehenter A, Leititis JU. von Willebrand factor-collagen binding activity is increased in newborns and infants. Acta Paediatr. 1995;84:697\u20139.","journal-title":"Acta Paediatr"},{"issue":"2\u20133","key":"3731_CR42","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0049-3848(02)00396-1","volume":"108","author":"HM Tsai","year":"2002","unstructured":"Tsai HM, Sarode R, Downes KA. Ultralarge von Willebrand factor multimers and normal ADAMTS13 activity in the umbilical cord blood. Thromb Res. 2002;108(2\u20133):121\u20135.","journal-title":"Thromb Res"},{"key":"3731_CR43","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1046\/j.1538-7933.2003.00575.x","volume":"2","author":"M Schmugge","year":"2004","unstructured":"Schmugge M, Dunn MS, Amankwah KS, Blanchette VS, Freedman J, Rand ML. The activity of the von Willebrand factor-cleaving protease ADAMTS-13 in newborn infants. J Thromb Haemost. 2004;2:228\u201333.","journal-title":"J Thromb Haemost"},{"issue":"9","key":"3731_CR44","doi-asserted-by":"publisher","first-page":"2730","DOI":"10.1182\/blood.V98.9.2730","volume":"98","author":"PM Mannucci","year":"2001","unstructured":"Mannucci PM, Canciani MT, Forza I, Lussana F, Lattuada A, Rossi E. Changes in health and disease of the metalloprotease that cleaves von Willebrand factor. Blood. 2001;98(9):2730\u20135.","journal-title":"Blood"},{"issue":"2","key":"3731_CR45","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1111\/j.1651-2227.2005.tb01892.x","volume":"94","author":"L Hellstrom-Westas","year":"2005","unstructured":"Hellstrom-Westas L, Ley D, Berg A-C, Kristoffersson A-C, Holmberg L. VWF-cleaving protease (ADAMTS13) in premature infants. Acta Paediatr. 2005;94(2):205\u201310.","journal-title":"Acta Paediatr"},{"issue":"4","key":"3731_CR46","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1365-2141.2007.06688.x","volume":"138","author":"HB Feys","year":"2007","unstructured":"Feys HB, Canciani MT, Peyvandi F, Deckmyn H, Vanhoorelbeke K, Mannucci PM. ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis. Brit J Haematol. 2007;138(4):534\u201340.","journal-title":"Brit J Haematol"},{"issue":"7","key":"3731_CR47","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1182\/blood.V73.7.1851.1851","volume":"73","author":"JA Katz","year":"1989","unstructured":"Katz JA, Moake JL, McPherson PD, Weinstein MJ, Moise KJ, Carpenter RJ, et al. Relationship between human development and disappearance of unusually large von Willebrand factor multimers from plasma. Blood. 1989;73(7):1851\u20138.","journal-title":"Blood"},{"issue":"1","key":"3731_CR48","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1365-2141.1989.tb07654.x","volume":"72","author":"MJ Weinstein","year":"1989","unstructured":"Weinstein MJ, Blanchard R, Moake JL, Vosburgh E, Moise K. Fetal and neonatal von Willebrand factor (vWF) is unusually large and similar to the vWF in patients with thrombotic thrombocytopenic purpura. Br J Haematol. 1989;72(1):68\u201372.","journal-title":"Br J Haematol"},{"issue":"1","key":"3731_CR49","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/09537104.2021.1962837","volume":"33","author":"F Ferrer-Marin","year":"2022","unstructured":"Ferrer-Marin F, Sola-Visner M. Neonatal platelet physiology and implications for transfusion. Platelets. 2022;33(1):14\u201322.","journal-title":"Platelets"},{"issue":"4","key":"3731_CR50","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1159\/000481016","volume":"2","author":"DG Corby","year":"1981","unstructured":"Corby DG, O\u2019Barr TP. Decreased alpha-adrenergic receptors in newborn platelets: cause of abnormal response to epinephrine. Dev Pharmacol Ther. 1981;2(4):215\u201325.","journal-title":"Dev Pharmacol Ther"},{"issue":"8","key":"3731_CR51","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3109\/09537104.2010.504869","volume":"21","author":"A Schlagenhauf","year":"2010","unstructured":"Schlagenhauf A, Schweintzger S, Birner-Gruenberger R, Leschnik B, Muntean W. Newborn platelets: lower levels of protease-activated receptors cause hypoaggregability to thrombin. Platelets. 2010;21(8):641\u20137. https:\/\/doi.org\/10.3109\/09537104.2010.504869.","journal-title":"Platelets"},{"issue":"8","key":"3731_CR52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183042","volume":"12","author":"E Caparros-Perez","year":"2017","unstructured":"Caparros-Perez E, Teruel-Montoya R, Lopez-Andreo MJ, Llanos MC, Rivera J, Palma-Barqueros V, et al. Comprehensive comparison of neonate and adult human platelet transcriptomes. PLoS ONE. 2017;12(8): e0183042. https:\/\/doi.org\/10.1371\/journal.pone.0183042.","journal-title":"PLoS ONE"},{"issue":"6","key":"3731_CR53","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/s0022-3476(73)80433-0","volume":"82","author":"GP Gross","year":"1973","unstructured":"Gross GP, Hathaway WE, McGaughey HR. Hyperviscosity in the neonate. J Pediatr. 1973;82(6):1004\u201312. https:\/\/doi.org\/10.1016\/s0022-3476(73)80433-0.","journal-title":"J Pediatr"},{"issue":"1","key":"3731_CR54","doi-asserted-by":"publisher","first-page":"R291","DOI":"10.1152\/ajpregu.2001.281.1.R291","volume":"281","author":"H Kajino","year":"2001","unstructured":"Kajino H, Chen Y-Q, Seidner SR, Waleh N, Mauray F, Roman C, et al. Factors that increase the contractile tone of the ductus arteriosus also regulate its anatomic remodeling. Am J Physiol Regul Integr Comp Physiol. 2001;281(1):R291\u2013301. https:\/\/doi.org\/10.1152\/ajpregu.2001.281.1.R291.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"1","key":"3731_CR55","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13052-019-0706-y","volume":"45","author":"J Mydam","year":"2019","unstructured":"Mydam J, Alok Rastogi A, Naheed ZJ. Base excess and hematocrit predict response to indomethacin in very low birth weight infants with patent ductus arteriosus. Ital J Pediatr. 2019;45(1):107. https:\/\/doi.org\/10.1186\/s13052-019-0706-y.","journal-title":"Ital J Pediatr"},{"issue":"6","key":"3731_CR56","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2016-1565","volume":"138","author":"N Tsujii","year":"2016","unstructured":"Tsujii N, Shiraishi I, Kokame K, Shima M, Fujimura Y, Takahashi Y, et al. Severe hemolysis and pulmonary hypertension in a neonate with Upshaw-Schulman syndrome. Pediatrics. 2016;138(6): e20161565. https:\/\/doi.org\/10.1542\/peds.2016-1565.","journal-title":"Pediatrics"},{"issue":"12","key":"3731_CR57","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1038\/nm1202-799","volume":"8","author":"CD Reiter","year":"2002","unstructured":"Reiter CD, Wang X, Tanus-Santos JE, Hogg N, Cannon RO 3rd, Schechter AN, et al. Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease. Nat Med. 2002;8(12):1383\u20139.","journal-title":"Nat Med"},{"key":"3731_CR58","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1097\/00005792-196603000-00003","volume":"45","author":"EL Amorosi","year":"1966","unstructured":"Amorosi EL, Ultmann JE. Thrombotic thrombocytopenic purpura: report of 16 cases and review of the literature. Medicine. 1966;45:136\u201360.","journal-title":"Medicine"},{"issue":"2\u20135","key":"3731_CR59","first-page":"141","volume":"18","author":"ME Wilkie","year":"1992","unstructured":"Wilkie ME, Stevens CR, Cunningham J, Blake D. Hypoxia-induced von Willebrand factor release is blocked by verapamil. Miner Electrolyte Metab. 1992;18(2\u20135):141\u20134.","journal-title":"Miner Electrolyte Metab"},{"issue":"2","key":"3731_CR60","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1172\/JCI118440","volume":"97","author":"DJ Pinsky","year":"1996","unstructured":"Pinsky DJ, Naka Y, Liao H, Oz MC, Wagner DD, Mayadas TN, et al. Hypoxia-induced exocytosis of endothelial cell Weibel-Palade bodies. A mechanism for rapid neutrophil recruitment after cardiac preservation. J Clin Invest. 1996;97(2):493\u2013500. https:\/\/doi.org\/10.1172\/JCI118440.","journal-title":"J Clin Invest"},{"issue":"4","key":"3731_CR61","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s12185-022-03324-w","volume":"115","author":"Y Fujimura","year":"2022","unstructured":"Fujimura Y, Holland LZ. COVID-19 microthrombosis: unusually large VWF multimers are a platform for activation of the alternative complement pathway under cytokine storm. Int J Hematol. 2022;115(4):457\u201369. https:\/\/doi.org\/10.1007\/s12185-022-03324-w.","journal-title":"Int J Hematol"},{"issue":"8","key":"3731_CR62","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1111\/j.1537-2995.2006.00914.x","volume":"46","author":"S Kato","year":"2006","unstructured":"Kato S, Matsumoto M, Matsuyama T, Isonishi A, Hiura H, Fujimura Y. Novel monoclonal antibody-based enzyme immunoassay for determining plasma levels of ADAMTS13 activity. Transfusion. 2006;46(8):1444\u201352. https:\/\/doi.org\/10.1111\/j.1537-2995.2006.00914.x.","journal-title":"Transfusion"},{"issue":"1","key":"3731_CR63","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/j.1365-2141.2005.05420.x","volume":"129","author":"K Kokame","year":"2005","unstructured":"Kokame K, Nobe Y, Kokubo Y, Okayama A, Miyata T. FRETS-VWF73, a first fluorogenic assay for ADAMTS13 activity. Br J Haematol. 2005;129(1):93\u2013100. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05420.x.","journal-title":"Br J Haematol"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03731-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-024-03731-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-024-03731-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T07:15:51Z","timestamp":1718608551000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-024-03731-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,27]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["3731"],"URL":"https:\/\/doi.org\/10.1007\/s12185-024-03731-1","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,27]]},"assertion":[{"value":"7 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This project had no outside support. YF receives a patent royalty for ADAMTS13-act-ELISA from Alfresa Pham. (Japan).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}